Regulatory And Financial Squeeze Tightens Around UK IVDs Sector
This article was originally published in Clinica
Growth in the £800m ($1.2bn) UK IVDs market has been driven in recent years by infectious immunology, immunochemistry and hematology, with clinical chemistry holding back the expansion. Current growth of the overall UK market is of the order of 1-2%. Volume testing has risen, but prices have not grown at the same rate, and in fact have trailed behind the inflation rate.
Register for our free email digests: